LITAF mediation of increased TNF-α secretion from inflamed colonic lamina propria macrophages

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Bushell, Kristen N ^a   Leeman, Susan E ^a   Gillespie, Earl ^a   Gower, Adam C ^b   Reed, Karen L ^b   Stucchi, Arthur F ^b   Becker, James M ^b   Amar, Salomon ^c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LITAF PROTEIN; MESSENGER RNA; MYELOPEROXIDASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; LIPOPOLYSACCHARIDE; LITAF PROTEIN, MOUSE; NUCLEAR PROTEIN; PEROXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; COLON; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; EX VIVO STUDY; KNOCKOUT MOUSE; LAMINA PROPRIA; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; WILD TYPE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; INFLAMMATION; METABOLISM; MUCOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALIA; MUS;

ANIMALS; BLOTTING, WESTERN; COLON; ENZYME-LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED C57BL; MUCOUS MEMBRANE; NUCLEAR PROTEINS; PEROXIDASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80053615114     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025849     Document Type: Article

References (41)

1. So T, Lee SW, Croft M, (2006) Tumor necrosis factor/tumor necrosis factor receptor family members that positively regulate immunity. Int J Hematol 83: 1-11.
2. Mannel DN, Echtenacher B, (2000) TNF in the inflammatory response. Chem Immunol 74: 141-161.
3. Cobrin GM, Abreu MT, (2005) Defects in mucosal immunity leading to Crohn's disease. Immunol Rev 206: 277-295.
4. Sandborn WJ, (2005) New concepts in anti-tumor necrosis factor therapy for inflammatory bowel disease. Rev Gastroenterol Disord 5: 10-18.
5. Kozuch PL, Hanauer SB, (2008) Treatment of inflammatory bowel disease: a review of medical therapy. World J Gastroenterol 14: 354-377.
6. Su C, Lichtenstein GR, (2005) Are there predictors of Remicade treatment success or failure? Adv Drug Deliv Rev 57: 237-245.
7. Goldfeld AE, Doyle C, Maniatis T, (1990) Human Tumor Necrosis Factor {alpha} Gene Regulation by Virus and Lipopolysaccharide. Proceedings of the National Academy of Sciences 87: 9769-9773.
8. Zhou J, Yang Z, Tsuji T, Gong J, Xie J, et al. LITAF and TNFSF15, two downstream targets of AMPK, exert inhibitory effects on tumor growth. Oncogene 30: 1892-1900.
9. Myokai F, Takashiba S, Lebo R, Amar S, (1999) A novel lipopolysaccharide-induced transcription factor regulating tumor necrosis factor alpha gene expression: molecular cloning, sequencing, characterization, and chromosomal assignment. Proc Natl Acad Sci U S A 96: 4518-4523.
10. Tang X, Fenton MJ, Amar S, (2003) Identification and functional characterization of a novel binding site on TNF-alpha promoter. Proc Natl Acad Sci U S A 100: 4096-4101.
11. Tang X, Marciano DL, Leeman SE, Amar S, (2005) LPS induces the interaction of a transcription factor, LPS-induced TNF-alpha factor, and STAT6(B) with effects on multiple cytokines. Proc Natl Acad Sci U S A 102: 5132-5137.
12. Stucchi A, Reed K, O'Brien M, Cerda S, Andrews C, et al. (2006) A new transcription factor that regulates TNF-alpha gene expression, LITAF, is increased in intestinal tissues from patients with CD and UC. Inflamm Bowel Dis 12: 581-587.
13. Bolcato-Bellemin AL, Mattei MG, Fenton M, Amar S, (2004) Molecular cloning and characterization of mouse LITAF cDNA: role in the regulation of tumor necrosis factor-alpha (TNF-alpha) gene expression. J Endotoxin Res 10: 15-23.
14. Zhu Y, Mahon BD, Froicu M, Cantorna MT, (2005) Calcium and 1alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur J Immunol 35: 217-224.
15. Tang X, Metzger D, Leeman S, Amar S, (2006) LPS-induced TNF-alpha factor (LITAF)-deficient mice express reduced LPS-induced cytokine: Evidence for LITAF-dependent LPS signaling pathways. Proc Natl Acad Sci U S A 103: 13777-13782.
16. Togashi H, Oikawa K, Adachi T, Sugahara K, Ito J, et al. (2003) Mucosal sulfhydryl compounds evaluation by in vivo electron spin resonance spectroscopy in mice with experimental colitis. Gut 52: 1291-1296.
17. Neurath M, Fuss I, Strober W, (2000) TNBS-colitis. Int Rev Immunol 19: 51-62.
18. Strober W, Fuss IJ, Blumberg RS, (2002) The immunology of mucosal models of inflammation. Annu Rev Immunol 20: 495-549.
19. Berg DJ, Davidson N, Kuhn R, Muller W, Menon S, et al. (1996) Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 98: 1010-1020.
20. Reed KL, Fruin AB, Gower AC, Gonzales KD, Stucchi AF, et al. (2005) NF-kappaB activation precedes increases in mRNA encoding neurokinin-1 receptor, proinflammatory cytokines, and adhesion molecules in dextran sulfate sodium-induced colitis in rats. Dig Dis Sci 50: 2366-2378.
21. Beutler E, Gelbart T, West C, (2001) Synergy between TLR2 and TLR4: a safety mechanism. Blood Cells Mol Dis 27: 728-730.
22. Weinstein SL, Gold MR, DeFranco AL, (1991) Bacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages. Proc Natl Acad Sci U S A 88: 4148-4152.
23. Reed KL, Fruin AB, Gower AC, Stucchi AF, Leeman SE, et al. (2004) A neurokinin 1 receptor antagonist decreases postoperative peritoneal adhesion formation and increases peritoneal fibrinolytic activity. Proceedings of the National Academy of Sciences 101: 9115-9120.
24. Abboud PA, Hake PW, Burroughs TJ, Odoms K, O'Connor M, et al. (2008) Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis. Eur J Pharmacol 579: 411-417.
25. Allison MC, Cornwall S, Poulter LW, Dhillon AP, Pounder RE, (1988) Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease. Gut 29: 1531-1538.
26. Ueda Y, Kayama H, Jeon SG, Kusu T, Isaka Y, et al. Commensal microbiota induce LPS hyporesponsiveness in colonic macrophages via the production of IL-10. International Immunology 22: 953-962.
27. Stramer BM, Mori R, Martin P, (2007) The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J Invest Dermatol 127: 1009-1017.
28. Kim HJ, Lee HS, Chong YH, Kang JL, (2006) p38 mitogen-activated protein kinase up-regulates LPS-induced NF-[kappa]B activation in the development of lung injury and RAW 264.7 macrophages. Toxicology 225: 36-47.
29. Ma W, Lim W, Gee K, Aucoin S, Nandan D, et al. (2001) The p38 Mitogen-activated Kinase Pathway Regulates the Human Interleukin-10 Promoter via the Activation of Sp1 Transcription Factor in Lipopolysaccharide-stimulated Human Macrophages. J Biol Chem 276: 13664-13674.
30. Lo CJ, (2003) MAPK regulation of prostaglandin E2 production by lipopolysaccharide-stimulated macrophages is not dependent on nuclear factor kappaB. J Surg Res 113: 189-194.
31. Sartor RB, (2006) Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 3: 390-407.
32. Baeuerle PA, Henkel T, (1994) Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12: 141-179.
33. Schreiber S, Nikolaus S, Hampe J, (1998) Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42: 477-484.
34. Karin M, Yamamoto Y, Wang QM, (2004) The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov 3: 17-26.
35. Kramer B, Meichle A, Hensel G, Charnay P, Kronke M, (1994) Characterization of an Krox-24/Egr-1-responsive element in the human tumor necrosis factor promoter. Biochimica et Biophysica Acta (BBA)- Gene Structure and Expression 1219: 413-421.
36. Goldfeld AE, McCaffrey PG, Strominger JL, Rao A, (1993) Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor alpha gene promoter. J Exp Med 178: 1365-1379.
37. Rhoades KL, Golub SH, Economou JS, (1992) The regulation of the human tumor necrosis factor alpha promoter region in macrophage, T cell, and B cell lines. J Biol Chem 267: 22102-22107.
38. Leitman DC, Ribeiro RC, Mackow ER, Baxter JD, West BL, (1991) Identification of a tumor necrosis factor-responsive element in the tumor necrosis factor alpha gene. J Biol Chem 266: 9343-9346.
39. Krämer B, Wiegmann K, Krönke M, (1995) Regulation of the Human TNF Promoter by the Transcription Factor Ets. J Biol Chem 270: 6577-6583.
40. Srinivasan S, Molecular analysis of LITAF-mediated inflammatory pathways [Thesis (D Sc)]: Boston University, Henry M. Goldman School of Dental Medicine, 2008 (Dept. of Oral Biology and Periodontology).
41. Pollastri MP, Whitty A, Merrill JC, Tang X, Ashton TD, et al. (2009) Identification and characterization of kava-derived compounds mediating TNF-alpha suppression. Chem Biol Drug Des 74: 121-128.